Table:
|  | 2019 | 2018 | 2017 |
| --- | --- | --- | --- |
| At 31 March | £m | £m | £m |
| Cash at bank and in hand | 495 | 446 | 469 |
| Cash equivalents |  |  |  |
| US deposits | 3 | 26 | 32 |
| UK deposits | 1,132 | 31 | 1 |
| Other deposits | 36 | 25 | 26 |
| Total cash equivalents | 1,171 | 82 | 59 |
| Total cash and cash equivalents | 1,666 | 528 | 528 |
| Bank overdrafts (note25) | (72) | (29) | (17) |
| Cash and cash equivalents per the cash flow statement | 1,594 | 499 | 511 |
Paragraphs:
24. Cash and cash equivalents
Significant accounting policies that apply to cash and cash equivalents Cash and cash equivalents comprise cash in hand and current balances with banks and similar institutions, which are readily convertible to cash and are subject to insignificant risk of changes in value and have an original maturity of three months or less. All are held at amortised cost on the balance sheet, equating to fair value. For the purpose of the consolidated cash flow statement, cash and cash equivalents are as defined above net of outstanding bank overdrafts. Bank overdrafts are included within the current element of loans and other borrowings (note 25).
IFRS 9 was applied for the first time on 1 April 2018 and introduces new classifications for financial instruments. Cash and cash equivalents were classified as loans and receivables under IAS 39, and are now classified as financial assets held at amortised cost under IFRS 9. This has not had an impact on the accounting for these instruments, or on their carrying amounts.
Cash and cash equivalents include restricted cash of £44m (2017/18: £32m, 2016/17: £43m), of which £40m (2017/18: £29m, 2016/17: £41m) was held in countries where local capital or exchange controls currently prevent us from accessing cash balances. The remaining balance of £4m (2017/18: £3m, 2016/17: £2m) was held in escrow accounts, or in commercial arrangements akin to escrow.
Question:
What is the change in the Cash at bank and in hand from 2018 to 2019?
Answer: 495 - 446 = 49